Altered cholesterol and fatty acid metabolism in Huntington disease
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in Journal of Clinical Lipidology
- Vol. 4 (1), 17-23
- https://doi.org/10.1016/j.jacl.2009.11.003
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Progress and Challenges in Metabolic Syndrome in Children and AdolescentsCirculation, 2009
- Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectinsThe FASEB Journal, 2009
- Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing CellsPublished by Elsevier BV ,2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanismsProstaglandins, Leukotrienes & Essential Fatty Acids, 2007
- Palmitoylation of huntingtin by HIP14is essential for its trafficking and functionNature Neuroscience, 2006
- Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington diseaseExperimental Neurology, 2005
- The Transcriptional Coactivators p300 and CBP Are Histone AcetyltransferasesCell, 1996
- Synergism in transcriptional activation: a kinetic view.Genes & Development, 1993
- Huntington's disease mortality in the United StatesNeurology, 1988